Increased levels of plasma haemoxygenase-1 in prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 14, Issue 2, 2011, Pages 114-117

  Blann, A D ^a   Balakrishnan, B ^a   Ryan, P ^b   Lip, G Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

angiogenesis; haemoxygenase 1; VEGF

Indexed keywords

ANGIOPOIETIN 2; ANTINEOPLASTIC AGENT; BICALUTAMIDE; FINASTERIDE; GOSERELIN; HAEMOXYGENASE 1; OXYGENASE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR;

AGED; ARTICLE; CANCER STAGING; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN PROTEIN INTERACTION;

AGED; ANGIOPOIETIN-2; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HEME OXYGENASE-1; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 79956141365     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2010.56     Document Type: Article

References (26)

1. Folkman J. What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6 (Pubitemid 20020880)
2. Jacobs EJ, Hsing AW, Bain EB, Stevens VL, Wang Y, Chen J et al. Polymorphisms in angiogenesis-related genes and prostate cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 972-977 (Pubitemid 351536431)
3. Ponka P. Cell biology of heme. Am J Med Sci 1999; 318: 241-256 (Pubitemid 30349676)
4. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1991; 03: 129-135
5. Ewing P, Wilke A, Eissner G, Holler E, Andreesen R, Gerbitz A. Expression of heme oxygenase-1 protects endothelial cells from irradiation-induced apoptosis. Endothelium 2005; 12: 113-119 (Pubitemid 41535018)
6. True AL, Olive M, Boehm M, San H, Westrick RJ, Raghavachari N et al. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 2007; 101: 893-901 (Pubitemid 350287176)
7. Rodella L, Lamon BD, Rezzani R, Sangras B, Goodman AI, Falck JR et al. Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes. Free Radic Biol Med 2006; 40: 2198-2205 (Pubitemid 43903106)
8. Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, Luxon BA et al. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 2008; 48: 1430-1439
9. Idriss NK, Blann AD, Lip GY. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 2008; 52: 971-978
10. Dulak J, Józkowicz A, Foresti R, Kasza A, Frick M, Huk I et al. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 2002; 4: 229-240 (Pubitemid 34517174)
11. Cisowski J, Loboda A, Józkowicz A, Chen S, Agarwal A, Dulak J. Role of heme oxygenase-1 in hydrogen peroxide-induced VEGF synthesis: effect of HO-1 knockout. Biochem Biophys Res Commun 2005; 326: 670-676 (Pubitemid 39642777)
12. Bussolati B, Mason JC. Dual role of VEGF-induced hemeoxygenase- 1 in angiogenesis. Antioxid Redox Signal 2006; 8: 1153-1163 (Pubitemid 44192315)
13. Maines MD, Abrahamsson PA. Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology 1996; 47: 727-733 (Pubitemid 26172743)
14. Gueron G, De Siervi A, Ferrando M, Salierno M, De Luca P, Elguero B et al. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Mol Cancer Res 2009; 7: 1745-1755
15. Caine GJ, Blann AD, Stonelake PS, Ryan P, Lip GY. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Eur J Clin Invest 2003; 33: 883-890 (Pubitemid 37215044)
16. Al-Mondhiry H, Manni A, Owen J, Gordon R. Hemostatic effects of hormonal stimulation in patients with metastatic prostate cancer. Am J Hematol 1988; 28: 141-145
17. Duque JL, Loughlin KR, Adam RM, Kantoff PW, Zurakowski D, Freeman MR. Plasma levels of VEGF are increased in patients with metastatic prostate cancer. Urology 1999; 54: 523-527 (Pubitemid 29407032)
18. Morsi WG, Shaker OG, Ismail EF, Ahmed HH, El-Serafi TI, Maklady FA et al. HO-1 and VEGF gene expression in human arteries with advanced atherosclerosis. Clin Biochem 2006; 39: 1057-1062 (Pubitemid 44737476)
19. Dulak JF, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase- 1 and carbon monoxide in vascular pathology: focus on angiogenesis. Circulation 2008; 117: 231-241
20. Jozkowicz A, Was H, Dulak J. Heme oxygenase-1 in tumours: is it a false friend? Antioxid Redox Signal 2007; 9: 2099-2117 (Pubitemid 350059009)
21. Jazwa A, Loboda A, Golda S, Cisowski J, Szelag M, Zagorska A et al. Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes. Free Radic Biol Med 2006; 40: 1250-1263
22. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost 2006; 95: 49-55
23. Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985; 42: 296-300 (Pubitemid 16244064)
24. Siner JM, Jiang G, Cohen ZI, Shan P, Zhang X, Lee CG et al. VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo. FASEB J 2007; 21: 1422-1432 (Pubitemid 46684845)
25. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Eaton JW et al. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res 2005; 49: 1030-1043 (Pubitemid 41735563)
26. Abdel Aziz MT, El-Miligy D, Amin MA, El Ansari A, Ahmed HH, Marzouk S et al. Molecular evaluation of apoptotic versus antiapoptotic angiogenic markers in hepatocellular carcinoma. Clin Biochem 2008; 41: 1008-1014